Page last updated: 2024-11-03

riluzole and Diabetic Retinopathy

riluzole has been researched along with Diabetic Retinopathy in 1 studies

Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.

Diabetic Retinopathy: Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.

Research Excerpts

ExcerptRelevanceReference
" We previously showed that the anti-amyotrophic lateral sclerosis (ALS) drug riluzole functions as a PKC inhibitor."7.85The anti-ALS drug riluzole attenuates pericyte loss in the diabetic retinopathy of streptozotocin-treated mice. ( Byun, HR; Choi, JA; Chung, YR; Koh, JY; Park, H; Yoon, YH, 2017)
" We previously showed that the anti-amyotrophic lateral sclerosis (ALS) drug riluzole functions as a PKC inhibitor."3.85The anti-ALS drug riluzole attenuates pericyte loss in the diabetic retinopathy of streptozotocin-treated mice. ( Byun, HR; Choi, JA; Chung, YR; Koh, JY; Park, H; Yoon, YH, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choi, JA1
Chung, YR1
Byun, HR1
Park, H1
Koh, JY1
Yoon, YH1

Other Studies

1 other study available for riluzole and Diabetic Retinopathy

ArticleYear
The anti-ALS drug riluzole attenuates pericyte loss in the diabetic retinopathy of streptozotocin-treated mice.
    Toxicology and applied pharmacology, 2017, Jan-15, Volume: 315

    Topics: Amyotrophic Lateral Sclerosis; Animals; Diabetic Retinopathy; Male; Mice; Mice, Inbred C57BL; Pericy

2017